Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents
- 1 December 2002
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 67 (6) , 461-465
- https://doi.org/10.1054/plef.2002.0457
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradictionMedical Hypotheses, 2000
- Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in VivoJournal of Biological Chemistry, 1999
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathwayBiochemical Pharmacology, 1996
- 15-Hydroxyprostaglandin dehydrogenaseJournal of Lipid Mediators and Cell Signalling, 1995
- Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.Journal of Clinical Investigation, 1995
- The mechanisms of action of nonsteroidal antiinflammatory drugsArthritis & Rheumatism, 1989
- ARACHIDONIC ACID METABOLISMAnnual Review of Biochemistry, 1986
- The Biological Activities of Three Metabolites of Prostaglandin E1Acta Physiologica Scandinavica, 1966